Q3 2017 13F Holders as of 9/30/2017
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
52.3M
-
Number of holders
-
111
-
Total 13F shares, excl. options
-
29.8M
-
Shares change
-
+756K
-
Total reported value, excl. options
-
$312M
-
Value change
-
+$7.64M
-
Put/Call ratio
-
2.05
-
Number of buys
-
58
-
Number of sells
-
-50
-
Price
-
$10.47
Significant Holders of ENZO BIOCHEM INC - Common Stock, par value $0.01 per share (ENZB) as of Q3 2017
136 filings reported holding ENZB - ENZO BIOCHEM INC - Common Stock, par value $0.01 per share as of Q3 2017.
ENZO BIOCHEM INC - Common Stock, par value $0.01 per share (ENZB) has 111 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 29.8M shares
of 52.3M outstanding shares and own 57.02% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (3.78M shares), BlackRock Inc. (3.72M shares), Evermore Global Advisors, LLC (3.69M shares), DIMENSIONAL FUND ADVISORS LP (2.15M shares), RENAISSANCE TECHNOLOGIES LLC (2.14M shares), VANGUARD GROUP INC (1.89M shares), ACADIAN ASSET MANAGEMENT LLC (1M shares), GILDER GAGNON HOWE & CO LLC (981K shares), TIAA CREF INVESTMENT MANAGEMENT LLC (736K shares), and STATE STREET CORP (679K shares).
This table shows the top 111 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.